Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures.
about
New developments in the clinical use of drug-coated balloon catheters in peripheral arterial diseaseMid-Term Outcomes of Stent Overlap in Long Total Occluded Lesions of Superficial Femoral Artery.In situ fracture of stents implanted for relief of pulmonary arterial stenosis in patients with congenitally malformed hearts.Endovascular stent treatment for symptomatic benign iliofemoral venous occlusive disease: long-term results 1987-2009Endovascular intervention for peripheral artery disease.Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) studyMidterm Outcome of Femoral Artery Stenting and Factors Affecting Patency.Indications and results with cryoplasty in the treatment of infrainguinal arterial occlusive disease.Carotid artery dynamics after carotid angioplasty and stenting.Current status of bare and drug-eluting stents in infrainguinal peripheral vascular disease.Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular injury in a porcine model.A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model.Development of a New Hybrid Biodegradable Drug-Eluting Stent for the Treatment of Peripheral Artery DiseaseA review of surgically treated patients with obstruction after stenting in the femoropopliteal artery region.An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.Effectiveness of Viabahn in the Treatment of Superficial Femoral Artery Occlusive Disease: A Systematic Review and Meta-analysis.Advances in Percutaneous Therapies for Peripheral Artery Disease: Drug-Coated Balloons.How should recent endovascular trials for femoropopliteal artery disease be interpreted?Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.Superficial Femoral Artery Intervention: Creating an Algorithmic Approach for the Use of Old and Novel (Endovascular) Technologies.Research and development of metals for medical devices based on clinical needs.Rotarex Mechanical Debulking in Acute and Subacute Arterial Lesions.Value of C-Arm Computed Tomography to Evaluate Stent Deployment During Femoro-Popliteal Revascularization.Factors Affecting the Results of Superficial Femoral Artery Stenting.Predictors of provisional stenting in patients undergoing lower extremity arterial interventions.Endovascular Treatment of Multilevel Chronic Total Occlusion Using a Stent Puncture Technique in Buerger's Disease.A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine.Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery.Superior mesenteric artery stent fracture producing stenosis and recurrent chronic mesenteric ischemia: case report.Crush Deformation of a Balloon-Expandable Stent Implanted in an Infrainguinal Bypass Graft.Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.Revascularization of the superficial femoral artery with paclitaxel-coated balloon for claudication.Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft.The breakage of a drug-eluting stent delivery system leading to limb amputation.A case of repeated occlusion in the common iliac artery due to an unexpected stent deformation.Restenosis and symptom recurrence after endovascular therapy for claudication: does duplex ultrasound correlate with recurrent claudication?Preprocedural Mean Platelet Volume Level Is a Predictor of In-Stent Restenosis of the Superficial Femoral Artery Stents in Follow-Up.Nitinol Stents in the Femoropopliteal Artery: A Mechanical Perspective on Material, Design, and Performance.
P2860
Q26740218-4526D038-7E76-4CDC-9D45-313FA3BB96ACQ33874462-37F5AF42-524B-4197-8E6C-4399ED5A56E8Q34530887-1810E043-AD5F-4B9C-B788-BE37652262C1Q34988219-889080E5-C149-4ABE-B700-F62E556578BFQ35857220-164442FC-C5E3-4BA0-B53F-B57787FEAC52Q36030828-2AEF2BE4-E00F-49F3-8BBF-26718EB631EBQ36411396-A54F3588-5170-4BD6-8191-5535560AB6B3Q36622321-524B1D2F-69B6-4573-A9EC-1CDA24AA9788Q36752071-097DE494-3248-4E98-BC37-DB575D37F0BCQ37134496-1B2BF1DB-64E9-43B3-8737-C18A796B3FD5Q37145994-A51B4305-94D1-4635-8A26-CEB4EB0CC3BEQ37257331-1B6E46BB-F204-49F9-93F6-BFE1642D8EE3Q37456910-7B2E8C04-2CD8-4DD2-8F45-0F1B8B0A4145Q37483241-D656D646-FF4E-47FE-B7EC-F9F878A86EB4Q38153045-14CD1AE0-9AA6-4F70-81B3-00283A5AFAC8Q38179363-A0129F6D-FCF7-4DB6-9CEF-412149332868Q38505073-EFA5835E-55CA-4D9E-BD86-4DC45EC5E887Q38608718-43335BCD-19E4-488E-B93F-7810E6CC086DQ38934274-B249A31D-B77E-43E8-9A35-A106D57D9F54Q38968545-93D95BCF-08EB-4837-A4EB-B847FC670544Q38975104-C51885FC-E33B-4ADE-8D76-A384B68749C0Q39017416-E53E36A8-055B-4A16-8DCF-1349A23470C3Q39754519-D3534F3C-9405-4F72-9378-60038368C5D6Q40279276-BC76AA80-738E-4581-A150-F7B7DB025486Q40302026-CF155793-264C-442A-8D89-C989FD1A6BAAQ41874821-525EF94C-F681-4452-9253-D021F1D728B3Q41964591-0ECFAE26-8A62-433F-B5F8-3A0054FF2891Q42273701-F9E1009E-0782-4302-8E37-3A9645E48C72Q47229750-495B4BD5-CF77-4724-B194-5B46B3201DB6Q47678305-F2860633-5C68-44AC-B37D-543F889D9D4DQ47946948-8BCE1541-9A69-4FB7-AAC8-9E156F340381Q48014828-1DD7AD4E-E8A8-4224-BFD7-E13CEE332510Q48123040-63628A4D-E039-4D3C-B5E6-25763ACDB9BFQ48569138-9882A5B3-1FCD-46E4-B1A3-BC965F9C7A6AQ48753214-1B14E676-7182-4111-9599-071A094D7348Q51233608-52DC6F7C-B9FD-4567-B3A9-24D053BBA302Q53552378-141EA7B9-E415-488A-A569-CECF85F67B05Q53561361-809FC000-B7ED-4FD5-B7AF-A75192C83852Q54956605-854FA24A-17C1-40FD-882C-C96118977DB0Q55025537-02FE2798-FC54-4F3F-8B92-3822D380CA08
P2860
Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Long-segment SFA stenting--the ...... ioration, and stent fractures.
@en
Long-segment SFA stenting--the ...... ioration, and stent fractures.
@nl
type
label
Long-segment SFA stenting--the ...... ioration, and stent fractures.
@en
Long-segment SFA stenting--the ...... ioration, and stent fractures.
@nl
prefLabel
Long-segment SFA stenting--the ...... ioration, and stent fractures.
@en
Long-segment SFA stenting--the ...... ioration, and stent fractures.
@nl
P2093
P356
P1476
Long-segment SFA stenting--the ...... ioration, and stent fractures.
@en
P2093
Erich Minar
Jasmin Amighi
Martin Schillinger
Oliver Schlager
Petra Dick
Schila Sabeti
Wolfgang Mlekusch
P304
P356
10.1583/05-1672.1
P577
2005-12-01T00:00:00Z